Breaking News Headlines Today | Ground News

Holiday Sale — Get 40% off Vantage for yourself or as a gift

Express Pharma image

News from Express Pharma

Ground News rates Express Pharma’s media bias as unknown. Ground News is unable to assign a bias rating and does not have ratings available from Ad Fontes Media, AllSides, and Media Bias/Fact Check.

Express Pharma’s factuality rating is Unknown. Ground News calculates this rating using a combination of the fact and reliability ratings from Ad Fontes Media and Media Bias/Fact Check.

Information about Express Pharma

Where is Express Pharma located?Express Pharma's Website

Media Bias Ratings

Do you disagree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Express Pharma News

FDA Approves First Daily Pill for Weight Loss Treatment — REUTERS / pwu404

Business · United States

FDA Approves First Daily Pill for Weight Loss Treatment

68% Center coverage: 227 sources

The U.S. Food and Drug Administration on Monday approved the first oral medication to treat obesity — a pill version of the weight-loss drug Wegovy. The pill contains semaglutide, the same active ingredient as injectable Wegovy and Ozempic.See the Story

Piramal Consumer Healthcare Updates Lacto Calamine’s Visual Identity

Piramal Consumer Healthcare Updates Lacto Calamine’s Visual Identity

New Delhi: Piramal Consumer Healthcare has refreshed the visual identity of its Lacto Calamine brand, updating the look of its long-standing purple bottle while retaining the original formulation that has been in use for decades. According to the company, the refreshed identity is intended to reflect contemporary skincare preferences while preserving the brand’s established association with oily-skin care. Lacto Calamine has gradually expanded …See the Story

Granules Pharma receives USFDA tentative approval for amphetamine ER ODT ANDA

Chantilly, Virginia · Chantilly

Granules Pharma receives USFDA tentative approval for amphetamine ER ODT ANDA

Granules Pharmaceuticals, a wholly owned subsidiary of Granules India, has received Tentative Approval from the United States Food and Drug Administration for its Abbreviated New Drug Application for Amphetamine Extended-Release Orally Disintegrating Tablets. The ANDA covers strengths of 3.1 mg, 6.3 mg, 9.4 mg, 12.5 mg, 15.7 mg and 18.8 mg. The product is the generic equivalent of ADZENYS XR-ODT and will be manufactured at Granules’ US-based fac…See the Story

Breaking News Topics Related to Express Pharma